Literature DB >> 24487366

Lipoprotein glomerulopathy may provide a key to unlock the puzzles of renal lipidosis.

Takao Saito1, Akira Matsunaga2.   

Abstract

Lipoprotein glomerulopathy is an inherited renal disease characterized by unique lipoprotein thrombi in the glomerulus and is associated with the APOE mutation. Hu and colleagues investigated the genetic and clinical features of a large group of patients with lipoprotein glomerulopathy who carried APOE Kyoto, a major APOE variant. Their findings suggest its descent through a founder effect. Fibrate therapy in this group showed favorable results in the patient and renal survival rates.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24487366     DOI: 10.1038/ki.2013.404

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

Review 1.  Foam cells and the pathogenesis of kidney disease.

Authors:  Minseob Eom; Kelly L Hudkins; Charles E Alpers
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-05       Impact factor: 2.894

2.  Nephrotic syndrome associated with severe hypertriglyceridemia in a pediatric patient: Answers.

Authors:  Beatriz Corredor-Andrés; María Teresa Muñoz-Calvo; Olga Calero; Cristina Aparicio; Jesús Argente; Miguel Calero
Journal:  Pediatr Nephrol       Date:  2018-03-12       Impact factor: 3.714

3.  Lipoprotein Glomerulopathy, First Case Report from Canada.

Authors:  Julie Anne Ting; Susanna A McRae; Daniel Schwartz; Sean J Barbour; Maziar Riazy
Journal:  Int J Nephrol Renovasc Dis       Date:  2022-06-21

Review 4.  An Updated Review and Meta Analysis of Lipoprotein Glomerulopathy.

Authors:  Meng-Shi Li; Yang Li; Yang Liu; Xu-Jie Zhou; Hong Zhang
Journal:  Front Med (Lausanne)       Date:  2022-05-06

Review 5.  Topics in lipoprotein glomerulopathy: an overview.

Authors:  Takao Saito; Akira Matsunaga; Kenji Ito; Hitoshi Nakashima
Journal:  Clin Exp Nephrol       Date:  2013-10-23       Impact factor: 2.801

Review 6.  Pathogenesis, histopathologic findings and treatment modalities of lipoprotein glomerulopathy: A review.

Authors:  Eduardo Cambruzzi; Karla Lais Pêgas
Journal:  J Bras Nefrol       Date:  2018-11-08

7.  Lipoprotein Glomerulopathy in a Hispanic Female: A Case Report and Literature Review.

Authors:  Nasma K Majeed; Jeanette McLaughlin; Miguel Gonzalez
Journal:  Can J Kidney Health Dis       Date:  2019-06-27

8.  Clinical and genetic analysis of lipoprotein glomerulopathy patients caused by APOE mutations.

Authors:  Mingxin Yang; Qinjie Weng; Xiaoxia Pan; Hafiz Muhammad Jafar Hussain; Shuwen Yu; Jing Xu; Xialian Yu; Yunzi Liu; Yuanmeng Jin; Chunli Zhang; Xiao Li; Hong Ren; Nan Chen; Jingyuan Xie
Journal:  Mol Genet Genomic Med       Date:  2020-05-22       Impact factor: 2.183

9.  Lipoprotein glomerulopathy resulting from compound heterogeneous mutations of APOE gene: A case report.

Authors:  Yunsi Li; Jin Chen; Yurong Zou; Wei Wang; Guisen Li
Journal:  Medicine (Baltimore)       Date:  2022-02-04       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.